The Sabin Vaccine Institute’s leadership team is comprised of a diverse group of global health, development and international relations experts.
Peter J. Hotez, M.D., Ph.D.
Bruce Gellin, M.D., M.P.H.
Brian Davis, CPA
Maria Elena Bottazzi, Ph.D.
Ana Flavia Carvalho, MBA, M.P.H.
David Diemert, M.D., F.R.C.P.(C.)
Denise Garrett, M.D., M.Sc.
Chief Executive Officer
Amy Finan was appointed as the Chief Executive Officer of the Sabin Vaccine Institute on April 18, 2016.
Prior to joining Sabin, Ms. Finan served as senior vice president responsible for business development at the Biotechnology Innovation Organization (BIO), the world's largest membership organization representing biotechnology companies, academic institutions and state biotechnology centers.
During her 11-year tenure at BIO, Ms. Finan played a critical role in expanding the organization’s membership and revenue base and implementing innovative approaches to fundraising, branding, marketing and programming. In 2011 and simultaneous with her BIO responsibilities, she also served as president of the Biotechnology Institute, an organization founded by BIO in 1998 to promote life science education.
Prior to BIO, Ms. Finan led corporate communications and investor relations for the former clinical-stage biotechnology company EntreMed Inc. Between 1999 and 2001, she created and implemented the biotech initiative of Montgomery County, Maryland, which included economic development policies, incubator programs, legislative packages and communication plans. Ms. Finan began her life sciences career as a government relations director for the National Association of Biomedical Research.
Ms. Finan studied at the London School of Economics & Political Science and graduated with a bachelor’s degree in political science from Trinity College in Washington, D.C. A native of Columbus, Ohio, Ms. Finan has lived in the Washington, DC, metropolitan area for more than 30 years and currently resides in Bethesda, Maryland, with her family.
President, Sabin Vaccine Institute, Director, Sabin Vaccine Institute and Texas Children's Hospital Center for Vaccine Development
Peter J. Hotez, M.D., Ph.D. is Dean of the National School of Tropical Medicine and Professor of Pediatrics and Molecular Virology & Microbiology at Baylor College of Medicine, where he is also the Texas Children’s Hospital Endowed Chair of Tropical Pediatrics. He is the President of the Sabin Vaccine Institute.
Dr. Hotez is an internationally-recognized physician-scientist in neglected tropical diseases and vaccine development. He leads the only product development partnership for developing new vaccines for schistosomiasis, hookworm infection, Chagas disease and SARS/MERS, diseases affecting hundreds of millions of children and adults worldwide. In 2006 at the Clinton Global Initiative he co-founded the Global Network for Neglected Tropical Diseases to provide access to essential medicines for hundreds of millions of people
He obtained his undergraduate degree in molecular biophysics from Yale University in 1980 (phi beta kappa), followed by a Ph.D. degree in biochemistry from Rockefeller University in 1986 and an M.D. from Weil Cornell Medical College in 1987.
Dr. Hotez has authored more than 400 original papers and is the author of Blue Marble Health: Neglected Diseases of the Poor Living Amidst Wealth (JHU Press) and the acclaimed Forgotten People, Forgotten Diseases (ASM Press).
Dr. Hotez served previously as President of the American Society of Tropical Medicine and Hygiene and is the founding Editor-in-Chief of PLoS Neglected Tropical Diseases. He is an elected member of the National Academy of Medicine (formerly the Institute of Medicine – IOM), and in 2011 he was awarded the Abraham Horwitz Award for Excellence in Leadership in Inter-American Health by the Pan American Health Organization of the World Health Organization.
Dr. Hotez served as a United States Science Envoy from 2015 to 2017, building science diplomacy initiatives between the U.S. Government and countries in the Middle East and North Africa at the behest of the White House and State Department. In 2015, Dr. Hotez was among the first to predict Zika’s emergence in the United States. He has been appointed to serve on Texas Governor Greg Abbott’s Task Force and appears regularly on television, radio and in newspaper interviews.
Bruce Gellin, M.D., M.P.H.
President, Global Immunization
Dr. Bruce Gellin joined the Sabin Vaccine Institute as the inaugural president of Global Immunization in March 2017. Prior to joining Sabin, Dr. Gellin served as the Deputy Assistant Secretary for Health and Director of the National Vaccine Program Office at the U.S. Department of Health and Human Services (HHS), where he was the principle technical, strategic and policy advisor to the Assistant Secretary for Health on all aspects of the National Vaccine Program.
In this role, Dr. Gellin served as a technical and policy advisor to the World Health Organization, focusing on influenza vaccines and global issues of vaccine hesitancy. In addition, he represented the U.S. government on the research and development focus of the Decade of Vaccines Collaboration and led the pandemic influenza preparedness and response activities of the Global Health Security Initiative.
At HHS, Dr. Gellin was responsible for developing the National Vaccine Plan, our country's blueprint for all aspects of vaccines and immunization. He also coordinated government-wide efforts on seasonal influenza and the corresponding opportunity to strengthen the adult immunization system in the United States. In 2005, he led the creation of HHS’s first pandemic influenza preparedness and response plan. Later, during the 2009 influenza pandemic, he led the U.S. team that donated H1N1 vaccine to other countries, expanded the nation’s vaccine safety monitoring system, and coordinated interagency efforts on vaccine development, supply and distribution.
Prior to joining HHS, Dr. Gellin founded and served as executive director of the National Network for Immunization Information, worked as a medical officer at the National Institute of Allergy and Infectious Diseases, served as Epidemic Intelligence Service officer at the Centers for Disease Control and Prevention (CDC), and was a Luce Scholar in the Philippines. Dr. Gellin’s global health work includes consulting for Gavi, the Vaccine Alliance, chairing the World Health Organization’s Global Action Plan for Influenza Vaccines Advisory Group, working with the Children’s Vaccine Initiative, and serving as a Warren Weaver fellow at the Rockefeller Foundation. He is one of the nation’s principle spokespersons on vaccines and immunizations and has served as on the faculty at Johns Hopkins Bloomberg School of Public Health, Columbia University’s Mailman School of Public Health and Vanderbilt University Medical School. He recently was appointed to Georgetown University Medical Center’s Department of Medicine as an adjunct professor in the Division of Infectious Diseases.
In 1991, Dr. Gellin earned an M.P.H. in epidemiology from the Columbia University Mailman School of Public Health. He is a graduate of Weill Cornell Medical College and was a Morehead Scholar at the University of North Carolina at Chapel Hill. He completed his internship and residency in internal medicine at Vanderbilt University and later was a preventive medicine resident at Cornell and at the CDC’s Arctic Investigations Program in Anchorage, Alaska. Dr. Gellin achieved board certification in internal medicine and infectious diseases, is an active member of numerous professional organizations, and serves as a peer reviewer for over a dozen medical journals.
In 2016, the Infectious Diseases Society of America awarded Dr. Gellin with the Society Citation in recognition of his work in the field of infectious diseases, and in 2015, he was bestowed the honor of the American Medical Association’s Nathan Davis Award for Outstanding Government Service for his leadership and vision while overseeing our nation’s vaccine and immunization initiatives.
Dr. Gellin and his family have lived in Washington, D.C., for the past 15 years.
Chief Operating Officer
Brian Davis has worked with the Sabin Vaccine Institute since 2005 and has served as their Chief Operating Officer since 2008. Prior to joining Sabin, Mr. Davis owned an established accounting practice in Washington, DC that served the non-profit sector in areas of life science, education, economic development and low-income housing. Mr. Davis holds CPA certificates in Maryland and the District of Columbia as well as a B.A. in Business Administration with a major in Finance from Michigan State University. Mr. Davis is a member of the American Institute of CPAs.
Deputy Director, Sabin Vaccine Institute Product Development Partnership and Director for Product Development, Sabin Vaccine Institute and Texas Children’s Hospital Center for Vaccine Development
Maria Elena Bottazzi, Ph.D. is the Associate Dean of the National School of Tropical Medicine and Professor of Pediatrics at Baylor College of Medicine in Houston, Texas. She also directs the Research and Administration of the new Section of Pediatric Tropical Medicine and leads the Product Development of the Sabin Vaccine Institute and Texas Children's Hospital Center for Vaccine Development.
Dr. Bottazzi moved in the Fall of 2011 to BCM and Texas Children’s from The George Washington University, where she had served as Associate Professor and Vice-Chair for Administration in the Department of Microbiology, Immunology and Tropical Medicine.
Dr. Bottazzi is an internationally-recognized scientist with more than 10 years experience in translational research and vaccine development for neglected tropical diseases. In addition, her major interest is the role of vaccines as control tools in international public health programs and initiatives.
She is a native of Tegucigalpa, Honduras, where she obtained her degree in Microbiology and Clinical Chemistry in 1989, followed by her Ph.D. in Molecular Immunology and Experimental Pathology at the University of Florida in Gainesville, FL, in 1995. Her post-doctoral training in Cellular Biology was completed during 1995-2001 at University of Miami and University of Pennsylvania. She became an assistant professor in 2001 after moving to the George Washington University.
Dr. Bottazzi is an Associate Editor for Public Library of Science (PLoS) Neglected Tropical Disease Journal and is the author or co-author of more than 60 scientific and technical papers in molecular, cellular biology, immunoparasitology, and vaccine development and is the recipient of multiple extramural awards.
Return to top
Ana Flavia Carvalho joined the Sabin Vaccine Institute in 2003. She leads international education and advocacy projects for new and under-utilized vaccines, including Sabin's annual vaccinology course and a global network for immunization managers.
Before joining Sabin, Ms. Carvalho was the Co-founder and Manager of a construction company that built houses for low-income families in the city of Campo Grande, Brazil. She also worked as the Senior Financial Analyst for Procter & Gamble in Brazil where she was primarily involved in business and project administration.
Ms. Carvalho received her bachelor’s degree in Office Automation Technology from the University of Technology in São Paulo, Brazil, a master’s degree in Business Administration from the Fundação Getulio Vargas (FGV) in Brazil and a master’s in Public Health degree from The George Washington University.
Return to top
Director, Clinical Trials, Sabin PDP, The George Washington University
Dr. David Diemert is Director of Clinical Development for the Sabin Vaccine Institute Product Development Partnership (Sabin PDP), which he joined in 2005. Dr. Diemert is also an associate professor in the Department of Microbiology, Immunology and Tropical Medicine at The George Washington University School of Medicine and Health Sciences.
Dr. Diemert provides direct oversight for vaccine trials sponsored by Sabin in the United States, Gabon, and Brazil. He has served as the Principal Investigator on multiple clinical trials of hookworm and malaria vaccines, as well as on epidemiology and controlled infection studies. His work in Brazil has involved preparing a trial site in partnership with the Fundação Oswaldo Cruz (FIOCRUZ), which has included establishing a clinic in a rural area of Brazil, assembling and training a Brazilian clinical trials team, establishing quality laboratory facilities at the field site, and conducting preparatory studies of helminth epidemiology and immunology.
Prior to joining the Sabin PDP, Dr. Diemert worked for four years at the Malaria Vaccine Development Branch of the National Institute of Allergy and Infectious Diseases, where he was responsible for conducting clinical trials of novel malaria vaccines, both in the United States and in Mali, West Africa.
Dr. Diemert earned his medical degree from the University of Alberta in Edmonton, Canada, and completed residency and fellowship training at McGill University in Montréal. He is a Fellow of the Royal College of Physicians (Canada) with certification in the specialties of internal medicine, infectious diseases and medical microbiology. Additionally, he received training in clinical tropical medicine through the University of Alabama at Birmingham's Gorgas Course in Lima, Peru.
Vice President, Typhoid Programs
Denise Garrett, M.D., M.Sc., joined Sabin Vaccine Institute in August 2015 to lead Sabin's work on typhoid. She serves as Director of the Coalition against Typhoid Secretariat and leads a large surveillance project to help determine the burden of typhoid in Asia. Dr. Garrett received her medical training in Brazil with special focus on infectious diseases, including typhoid fever.
For the past 23 years, Denise worked at the Centers for Disease Control and Prevention (CDC) where she focused on international health and epidemiologic research, leading several multicenter research studies. During her tenure with CDC, Dr. Garrett led several multicenter infectious disease studies in developing and developed countries. Denise brings extensive experience collaborating with international governments, multilateral agencies, universities, private sector, non-governmental, and global health organizations to expand infectious disease control and prevention, and outbreak response programs around the world.
Vice President, Resource Development & Policy
Tara Hayward is Vice President of Resource Development and Policy at the Sabin Vaccine Institute. She oversees fundraising and public policy activities related to Sabin’s work to reduce vaccine-preventable and neglected tropical diseases. Since 2010, she has led the development department, securing funding from governments, foundations, corporations and high net worth individuals. She also oversees Sabin’s United Kingdom operations through Sabin Foundation Europe.
Prior to joining Sabin, Ms. Hayward served as the manager of development for the International Women's Media Foundation, where she was responsible for creating and managing the infrastructure and operations of annual giving, foundation and corporate fundraising, and special events. Her prior experience also includes working for the United Nations Population Fund in Bosnia and Herzegovina and serving in the Peace Corps in Romania.
She holds a Master’s degree in International Development from the University of Denver in the Josef Korbel School of International Studies and a bachelor’s degree from DePauw University, where she majored in English writing.
Kathryn McGrath is the Communications Director at the Sabin Vaccine Institute. She leads communications for all of Sabin’s programs and directs the END7 campaign to end the most common neglected tropical diseases. Since working for the world’s first instant messenger and largest online community, ICQ, she has spent more than a decade helping non-profit organizations go digital.
Prior to joining Sabin, she worked for the Natural Resources Defense Council in New York where she developed advocacy campaigns and digital content. She graduated from the University of Washington with a bachelor’s degree in English.